The Use of Brief Assessment Batteries in Multiple Sclerosis Robert L. Kane, Ph.D. ABPP-Cn Assoc. Director Communications VA MSCE East.

Slides:



Advertisements
Similar presentations
ASSESSING RESPONSIVENESS OF HEALTH MEASUREMENTS. Link validity & reliability testing to purpose of the measure Some examples: In a diagnostic instrument,
Advertisements

Assessment of Reliable Change: Methods and Assumptions Michael Basso, Ph.D. Associate Professor and Director of Clinical Training Department of Psychology—University.
Speed of processing, the missing measure in early detection of MCI? Ruth O’Hara March 13 th 2001 Yogesh Shah.
Psychological Assessment
MemTrax (Computerized Memory Screen) American Association of Geriatric Psychiatry (AAGP) March 2, 2007 J. Wesson Ashford, M.D., Ph.D. Stanford / VA Aging.
DRAFT Promotional Copy for NNSDO 1 Cognitive / Mental Status Assessment of Older Adults.
Neurocognitive Manifestations in ME/CFS Gudrun Lange, PhD Professor Department of Physical Medicine and Rehabilitation, Rutgers-NJMS.
Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults.
Copyright © 2008 Pearson Education, inc. or its affiliates. All rights reserved. An Introduction to Advanced Clinical Solutions for the WAIS-IV and WMS-IV.
Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.
Rivermead Behavioural Memory Test performance in schizophrenic patients Ruiz, J.C. (1), Fuentes, I. (1), Tomás, P. (2), Soler, M.J. (1) and García Merita,
Including Cognitive Disabilities in International Standards David Fourney Department of Computer Science, University of Saskatchewan, Saskatoon, Saskatchewan,
The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
Author: Sabrina Hinton. Year and Publisher: American Guidance Service.
Multiple Sclerosis: A Neuropsychological Perspective National Multiple Sclerosis Society: Eastern North Carolina Chapter Antonio E. Puente, Ph.D. University.
Athleticism, like intelligence, is many things
Jared A. Rowland, M.S., Michael M. Knepp, M.S., Sheri L. Towe, M.S., Chris S. Immel, M.S., Ryoichi J.P. Noguchi, M.S., Chad L. Stephens, M.S. & David W.
Barbara A. Wilson, Eve Greenfield, Linda Clare, Alan Baddeley, Janet Cockburn, Peter Watson, Robyn Tate, Sara Sopena, Rory Nannery & John Crawford (2008)
Wechsler Adult Intelligence Scales
Chair Timothy L. Vollmer, MD Professor of Neurology
Emotion Perception and Social Functioning in Serious Mental Illness: Differential Relationships Among Inpatients and Outpatients Melissa Tarasenko, Petra.
Introduction History of Childhood Abuse and Recovery of Neurocognition during Inpatient Psychiatric Rehabilitation: 18-Month Longitudinal Study Kee-Hong.
TM 1.
Introduction Multiple Sclerosis (MS) is a chronic inflammatory disease characterized by the demyelization of axons within the central nervous system (CNS).
IQ Testing & Brain Damage. Full Scale IQ Person’s relative standing in comparison w/ age- related peers and global estimate of overall mental abilities.
MEMORY ASSESSMENT in the LAB vs. the CLINIC
Assessing Change in Clinical Practice Richard Bost, Ph.D., ABPP Frances Wen, Ph.D. Michael Basso, Ph.D Oklahoma Psychological Association 11/6/04.
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
Trends in Locus of Control Beliefs and Biosystemic Levels of Functioning in Inpatients with Serious Mental Illness Introduction Method Results Discussion.
Power Point and Syllabus h3443.html.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
Competency in Older Adults: Clinical and Legal Perspectives The Role of Cognitive and Neuropsychological Evaluations John Crumlin, PhD Assistant Director,
Cognitive Development Across Adulthood Lecture 11/29/04.
Method IntroductionResults Discussion Do coping strategies & control beliefs change with rehabilitation? The role of neurocognition in the relationship.
CC-1 Benefit-Risk Assessment Murat Emre, MD Professor of Neurology Istanbul Faculty of Medicine Department of Neurology Behavioral Neurology and Movement.
METHOD METHOD Long-Term Neuropsychological Functioning Following Mild Traumatic Brain Injury Nathalie C. Bérard and Dennis P. Alfano CONCLUSIONS The group.
Wechsler Scales. Security and Terms Test security Test security Terms Terms Floor Floor Ceiling Ceiling Basal and ceiling rules Basal and ceiling rules.
MethodIntroductionResults Discussion Factors Affecting Psychosocial Functioning in Serious Mental Illness and Implications for Treatment Jason E. Vogler,
Psychological Testing
Assessing Responsiveness of Health Measurements Ian McDowell, INTA, Santiago, March 20, 2001.
Leiter International Performance Scale – Revised
روانشناسی عصب شناختی Evaluation and treatment of individuals with brain dysfunction.
Chapter 6 - Standardized Measurement and Assessment
Identifying and Tracking Changes in Cognition Related to NPH Sheldon Herring, Ph.D. Clinical Director Outpatient Brain Injury and Young Stroke Program.
Decision-Making Capacity - under the medical model Dr. Michael A. Valente.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Cognitive Testing, Statistics and Dementia Ralph J. Kiernan Ph.D. 14 th May 2013.
PANDHARIPANDE PP ET AL. N ENGL J MED 2013; 369: Long-Term Cognitive Impairment after Critical Illness.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Orienting network dysfunction in progressive multiple sclerosis (ID 208) Chalah MA 1,2, Palm U 1,3, Nguyen R 1,4, Créange A 1,4, Lefaucheur JP 1,2, Ayache.
The Clinical Utility of the LANSE- A and LANSE-C Jennifer L. Harrison, M.A., Megan Pollock, M.A., Amy Mouanoutoua, M.A. Ashley Brimager, M.A., & Paul C.
The Reliability and Validity of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) in Persons with Post-Acute Traumatic Brain Injury (TBI)
Insights into Verbal Planning Total score of core propositions
Rachel L. Fazio, Psy. D. , Allison N. Faris, Psy. D. , Karim Z
Wechsler Test-Retest Combinations
Intelligence Andrea Mejia Spring 2017.
Associate Director, Biostatistics
Brief Computerized Measures of Information Processing Speed are Sensitive to Multiple Sclerosis across the Lifespan M. Shaw1, C. Schwarz1, L.B. Krupp1,
Volume 9, Pages 3-7 (December 2017)
FUNDING ACKNOWLEDGEMENT
University of South Alabama Neurobehavioural Associates
Neuro-psychological Tests
Brief Visuospatial Memory Test- Revised™ (BVMT-R™) Ralph H
PSY 614 Instructor: Emily Bullock, Ph.D.
Nat. Rev. Neurol. doi: /nrneurol
TESTING AND EVALUATION IN EDUCATION GA 3113 lecture 1
Decision-Making Capacity - under the medical model
Assessment Chapter 3.
Presentation transcript:

The Use of Brief Assessment Batteries in Multiple Sclerosis Robert L. Kane, Ph.D. ABPP-Cn Assoc. Director Communications VA MSCE East

Brief NP Assessment-Kane Slide #22 History of Cognitive Studies in MS Since MS is a CNS disorder is there a cognitive component What is the severity With what frequency does it occur Is there a particular pattern or presentation Does the pattern or severity vary with subtype of course

Brief NP Assessment-Kane Slide #33 Clinical Questions Who needs to be assessed What cognitive domains need to be covered With what frequency should the assessments take place Strategies for assessment related to purpose Comprehensive: Assessment for rehabilitation, benefits, vocational planning Detection: Identification of individuals showing deficits Monitoring: Assessing cognitive changes as a treatment outcome

Brief NP Assessment-Kane Slide #44 Neurocognitive Assessment as Review of Systems Neurologic Musculoskeletal Cardiovascular Respiratory GI GU Integumentary (skin) (Pain) Attention Immediate memory Sustained focused Working memory divided Memory Learning Recall Recognition Language Fluency Comprehension Repetition Problem Solving Executive Functioning Processing Speed

Brief NP Assessment-Kane Slide #55 Strategy If you have a population where ~50% of the patients may have problems does it make sense to screen first before embarking on a comprehensive exam? Is there sufficient consistency in deficits to permit short screening approaches? Can short batteries be used to monitor treatment progression and outcome?

Brief NP Assessment-Kane Slide #66 Characteristics of a Screening Examination Brief Inexpensive Sample pertinent disease parameters (domains, constructs, predictability) Balance Sensitivity and Specificity Sensitivity: ability to make correct identification ( detect true positives ) Specificity: ability to not identify everything else in the process (minimize false positives)

Brief NP Assessment-Kane Slide #77 Characteristics of a Screening Examination: for sequential monitoring Brief Inexpensive Sample pertinent disease parameters Balance Sensitivity and Specificity Repeatable with methods of identifying meaningful change Repeatable with methods of identifying meaningful change

Brief NP Assessment-Kane Slide #88 Screening Approaches MSNQ (MS Neuropsychological Screening Questionnaire) MMSE (Mini Mental Status Examination) BRB-N (Brief Repeatable Battery-Neuropsychological BNPB (Brief Neuropsychological Battery) SEFCI (Screening Examination for Cognitive Impairment) RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) BSB (Basso Screening Battery) MACFIMS (Minimal Assessment of Cognitive Function in MS) ANAM (Automated Neuropsychological Assessment Metrics)

Brief NP Assessment-Kane Slide #99 Dimensions for Battery Review Time Yield Repeatability Sensitivity/Specificity

Brief NP Assessment-Kane Slide #1010 MSNQ MS Neuropsychological Screening Questionnaire Time 5 min (patient and informant) Yield Reported symptoms of cognitive and behavioral problems Repeatability Utility as change measure not established Sensitivity/Specificity (Informant) 1 Sensitivity:.83 Specificity:.97 [1] Benedict R et al (2003) Mult Sclr. V

Brief NP Assessment-Kane Slide #1111 MMSE Mini Mental Status Examination Time 5-10 minutes Yield Global summary score Repeatability Single form Sensitivity/Specificity 1 Sensitivity: 21-36% MS Generally poor with specific or subcortical lesions Specificity: % [1] Fischer JS (2001) in SD Cook (Ed) Handbook of MS 3 rd ed.

Brief NP Assessment-Kane Slide #1212 BRB-N Brief Repeatable Battery-Neuropsychological Time minutes Yield Selective Reminding, 10/36 Spatial Recall, PASAT, Digit Symbol Modalities, COWA Repeatability Some measures have alternative forms Not all alternate forms are equivalent

Brief NP Assessment-Kane Slide #1313 BRB-N Brief Repeatable Battery-Neuropsychological Sensitivity/Specificity (memory) Sensitivity: 93% 1 Specificity: 48% Sensitivity 1+ impaired tests:41.9% 2 2+ impaired tests: 16.2% Performance and performance changes correlated with MRI findings 3 [1] Dent A & Lincoln NB (2000) Br J Clin Psychol v39 p [2] Solari A. et al. (2002) Mult Scler v8 p [3] Hohol MJ et al (1997) Arch Neurol v54 p

Brief NP Assessment-Kane Slide #1414 BNPB Brief Neuropsychological Battery Time 20 min Yield Selective Reminding, 7/24 Spatial Recall, PASAT, COWA Repeatability Alternate forms available for most measures Sensitivity/Specificity Sensitivity: 71% 1 Specificity: 94% Sensitivity: 68% 2 Specificity: 85% [1] Rao SM et al. (1991) Neurology v41 p [2] Fischer JS (2001) in SD Cook (Ed) Handbook of MS 3 rd ed.

Brief NP Assessment-Kane Slide #1515 SEFCI Screening Examination for Cognitive Impairment Time min Yield List learning and recall, Symbol Digit Modalities, Shipley ILS Repeatability Alternate forms not available for all measures

Brief NP Assessment-Kane Slide #1616 SEFCI Screening Examination for Cognitive Impairment Sensitivity/Specificity 1 86% : 1+ cog measure 100%: 3+ cog domains 90%: 0 cog domains Sensitivity/Specificity 2 Sensitivity: 74-86% Specificity: 90-91% Sensitivity 3 1+ impaired tests: 31.5% 2+ impaired tests: 18.5% [1] Beatty WW et al (1995) Neurology v45 p [2] Fischer JS (2001) in SD Cook (Ed) Handbook of MS 3 rd ed [3] Solari et al (2002) Mult Sclr v8 p

Brief NP Assessment-Kane Slide #1717 RBANS Repeatable Battery for the Assessment of Neuropsychological Status Time 25 Minutes Yield Index scores Individual test norms now available Repeatability 2 alternate forms Supplemental release contains change score information Sensitivity/Specificity 1 =MMSE <BNPB <SEFCI [1] Aupperle RL et al. (2002) Mult Sclr v8 p

Brief NP Assessment-Kane Slide #1818 BSB Basso Screening Battery Time 20 min Yield Logical Memory, COWA, Seashore Rhythm, graphesthesia, sterognosis Repeatability No alternate form for memory measure Sensitivity/Specificity 1 Sensitivity: 100% (not independent of criterion) Specificity: 80% (not independent of criterion) [1] Basso MR et al. (1996) Arch Neurol v53 p

Brief NP Assessment-Kane Slide #1919 MACFIMS Minimal Assessment of Cognitive Function in MS Time 90 Min Yield Working Memory, Processing Speed, Learning/Memory, Executive Functioning, Perception/Spatial Processing, Word Fluency Repeatability Alternate forms available for most measures Sensitivity/Specificity Benedict RHB et al (2002) Clin Neuropsyol v16 p

Brief NP Assessment-Kane Slide #2020 ANAM Automated Neuropsychological Assessment Metrics Time ~25 Minutes Yield Scores related to processing speed/attention, working memory, memory, executive fx Repeatability Multiple computer produced forms Sensitivity/Specificity 1 Time 1 Sensitivity: 87.5% Specificity: 97.5 Time 2 Sensitivity: 85.7% Specificity: 100% [1] Wilken J et al. (2003) Mult Sclr v9 p

Brief NP Assessment-Kane Slide #2121 Sensitivity in Early MS Classification Agreement MS Patients: Time 1 Computerized Tests IntactImpairedPercent Correct Traditional Measures Intact Impaired Overall Rate95.8 Classification Agreement MS Patients: 6 Month Follow-up Computerized Tests IntactImpairedPercent Correct Traditional Measures Intact Impaired Overall Rate97.2

Brief NP Assessment-Kane Slide #2222 Attention/Processing Construct Validity: Correlation of indicator tests with latent construct

Brief NP Assessment-Kane Slide #2323 Working Memory Construct Validity: Correlation of indicator tests with latent construct

Brief NP Assessment-Kane Slide #2424 DS Back LNS Tot MathTP Arith Tot Note. Arith Tot = Wechsler Adult Intelligence Scale- III (WAIS-III) arithmetic total score. DS Back = WAIS-III digit span backward. LNS Tot = WAIS-III letter-number sequencing total score. Math TP = ANAM Math TP score. Working Memory Construct Validity - Working Memory N = 65.  2 (2)=1.94, GFI = 0.99, RMSEA=.00

Brief NP Assessment-Kane Slide #2525 DS Back LNS Tot RM TP Arith Tot Note. Arith Tot = Wechsler Adult Intelligence Scale- III (WAIS-III) arithmetic total score. DS Back = WAIS-III digit span backward. LNS Tot = WAIS-III letter-number sequencing total score. RM TP = ANAM Running Memory TP score. Working Memory Construct Validity - Working Memory N = 65.  2 (2)=1.31, GFI = 0.99, RMSEA=.00

Brief NP Assessment-Kane Slide #2626 Note. CVLTSav = California Verbal Learning Test savings score; HS Loss =Heaton Story percentage loss T-score; HF Loss =Heaton Figure percentage loss T-score; MTSTP =WinSCAT Matching to sample thtroughput. CVLTSav HS Loss HF Loss MTSTP Memory n = 66  2 (2)=1.15, GFI =.99. RMSEA=.00 Memory Construct in a Clinical Sample Matching to Sample Throughput

Brief NP Assessment-Kane Slide #2727 Remote ANAM

Brief NP Assessment-Kane Slide #2828 Reliable Change Index (RCI) RCI = (postest – baseline) / SE meas Where SE meas = sd baseline * sqrt(1-r xx ) r xx is the reliability of the measure Baseline = sd of last three trials prior to observations of interest Assumption: Once stable baseline has been attained, differences among an individual’s scores are due to measurement error Changes significantly greater than measurement error reflect true change (<= 95% confidence interval)

Brief NP Assessment-Kane Slide #2929 Number of Significant Changes to RCI

Brief NP Assessment-Kane Slide #3030 Summary Compelling reasons to make neurocognitive assessment more obtainable Data support the focus on using brief screens to identify individuals in need of further assessment Focus should also be on patient monitoring Selecting measures that are repeatable Developing good procedures for assessing change